Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
Boostrix
Description:
A brand of combined tetanus, diphtheria, and acellular pertussis vaccine used as a booster in adolescents and adults.
Primary topic:
Bacterial Infections and Vaccines (58%)
Related topics:
Bacterial Infections and Vaccines (58%),
Diphtheria, Corynebacterium, and Tetanus (20%)
OpenAlex ID:
keywords/boostrix
Preventing Tetanus, Diphtheria, and Pertussis Among Adolescents: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
2006
·
Karen R. Broder
, Margaret M. Cortese
, et al.
·
PsycEXTRA Dataset
·
532
Pertussis vaccination during pregnancy in Belgium: Results of a prospective controlled cohort study
2015
·
Kirsten Maertens
, Raïssa Nadège Caboré
, et al.
·
Vaccine
·
188
Estimating the Effectiveness of Tetanus-Diphtheria-Acellular Pertussis Vaccine (Tdap) for Preventing Pertussis: Evidence of Rapidly Waning Immunity and Difference in Effectiveness by Tdap Brand
2014
·
Ruth Koepke
, Jens C. Eickhoff
, et al.
·
The Journal of Infectious Diseases
·
164
Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older - Advisory Committee on Immunization Practices (ACIP), 2012.
2012
·
PubMed
·
115
Prevention of Pertussis Among Adolescents: Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine
2006
·
PEDIATRICS
·
115
Pertussis vaccination during pregnancy in Belgium: Follow-up of infants until 1 month after the fourth infant pertussis vaccination at 15 months of age
2016
·
Kirsten Maertens
, Raïssa Nadège Caboré
, et al.
·
Vaccine
·
104
PDF
Effectiveness of maternal pertussis vaccination in preventing infection and disease in infants: The NSW Public Health Network case-control study
2018
·
Nathan Saul
, Kevin Wang
, et al.
·
Vaccine
·
98
PDF
Immunogenicity of a single dose of reduced-antigen acellular pertussis vaccine in a non-vaccinated adolescent population
2005
·
Markus Knuf
, Fred Zepp
, et al.
·
Vaccine
·
76
Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix®): Results of two randomized trials
2011
·
Wayde M. Weston
, Leonard R. Friedland
, et al.
·
Vaccine
·
69
A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix™) is immunogenic and well tolerated in adults
2010
·
Robert Booy
, Olivier Van Der Meeren
, et al.
·
Vaccine
·
69
Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19–64 years of age
2008
·
Mark Blatter
, Leonard R. Friedland
, et al.
·
Vaccine
·
60
Immunogenicity of a combined diphtheria–tetanus–acellular pertussis vaccine in adults
2003
·
Pierre Van Damme
, Margaret Burgess
·
Vaccine
·
51
Pertussis Immunity and Response to Tetanus-Reduced Diphtheria-Reduced Pertussis Vaccine (Tdap) after Autologous Peripheral Blood Stem Cell Transplantation
2009
·
Trudy N. Small
, Andrew D. Zelenetz
, et al.
·
Transplantation and Cellular Therapy
·
42
PDF
Post-Marketing Safety Evaluation of a Tetanus Toxoid, Reduced Diphtheria Toxoid and 3-Component Acellular Pertussis Vaccine Administered to a Cohort of Adolescents in a United States Health Maintenance Organization
2010
·
Nicola P. Klein
, John Hansen
, et al.
·
The Pediatric Infectious Disease Journal
·
41
Persistence of antibodies 3 years after booster vaccination of adults with combined acellular pertussis, diphtheria and tetanus toxoids vaccine
2011
·
Wayde Weston
, Marc Messier
, et al.
·
Vaccine
·
39
FDA approval of expanded age indication for a tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine.
2009
·
PubMed
·
38
Pertussis Vaccines for Adolescents and Adults
2005
·
James D. Cherry
·
PEDIATRICS
·
32
Anti-diphtheria antibody seroprotection rates are similar 10 years after vaccination with dTpa or DTPa using a mathematical model
2004
·
Brigitte Cheuvart
, Margaret Burgess
, et al.
·
Vaccine
·
30
Reduced-Antigen, Combined Diphtheria, Tetanus and Acellular Pertussis Vaccine, Adsorbed (Boostrix®): A Review of its Properties and Use as a Single-Dose Booster Immunization
2012
·
Paul L. McCormack
·
Drugs
·
29
Safety and immunogenicity of a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine when co-administered with influenza vaccine in adults
2009
·
Wayde M. Weston
, Vijayalakshmi Chandrashekar
, et al.
·
Human Vaccines
·
29
Optimising the timing of whooping cough immunisation in mums (OpTIMUM) through investigating pertussis vaccination in pregnancy: an open-label, equivalence, randomised controlled trial
2023
·
Anna Calvert
, Gayatri Amirthalingam
, et al.
·
The Lancet Microbe
·
28
Immunogenicity of the reduced-antigen-content dTpa vaccine (Boostrix®) in adults 55 years of age and over: A sub-analysis of four trials
2011
·
Pierre Van Damme
, Peter McIntyre
, et al.
·
Vaccine
·
28
Repeated administration of a reduced-antigen-content diphtheria-tetanus-acellular pertussis and poliomyelitis vaccine (dTpa-IPV;Boostrix™IPV)
2010
·
Markus Knuf
, Volker Vetter
, et al.
·
Human Vaccines
·
28
Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces B. pertussis nasal colonization
2023
·
Kacy S. Yount
, Jesse M. Hall
, et al.
·
Frontiers in Immunology
·
26
Highly Sensitive Flow Cytometry Allows Monitoring of Changes in Circulating Immune Cells in Blood After Tdap Booster Vaccination
2021
·
Annieck M. Diks
, Indu Khatri
, et al.
·
Frontiers in Immunology
·
26
Show more works
View as search
Works count:
131
Citation count:
2,385
Year
Topic
Type